Global, Regional, and National Burden of Hematologic Malignancies From 1990 to 2021, With Projections of Mortality and Incidence to 2031
Psycho-Oncology · 2026
DOI: 10.1002/pon.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2026. Verfasst von Yanqi Kou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Hen…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Global Health. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Big Data Platform of Affiliated Hospital of Guangdong Medical University, the In-Hospital Funding Clinical Research Project of the Affiliated Hospital of Guang…, Guangdong Provincial Medical Science and Technology Research Fund Project.
Abstract (Originalsprache)
Background
Global analyses of hematologic malignancies often lack subtype integration and advanced forecasting, limiting public health planning.
Methods
Using GBD 2021 data (1990–2021), we analyzed age‐standardized incidence (ASIR), mortality (ASDR), and disability‐adjusted life years (DALYs) for leukemia, lymphoma, and multiple myeloma. Spatiotemporal models quantified age‐, sex‐, and Socio‐demographic Index (SDI)‐stratified disparities. The Prophet model forecasted trends to 2031.
Results
In 2021, global ASIRs were 5.63, 7.93, and 1.74 per 100,000 for leukemia, lymphoma, and multiple myeloma, respectively. ASIR correlated positively with SDI for all subtypes (e.g., multiple myeloma: ρ = 0.81, p < 0.001). Mortality patterns were heterogeneous; Hodgkin lymphoma ASDR correlated negatively with SDI ( ρ = −0.26, p < 0.001). Projections suggest stable or declining ASDRs by 2031 (e.g., leukemia: 3.86 to 3.40) but persistent male predominance. DALYs remain high in low‐SDI regions.
Discussion
The disparity between high incidence in high‐SDI areas and higher mortality fractions in low‐SDI areas underscores diagnostic and therapeutic inequities. DALYs reflect associated long‐term functional and psychosocial burden.
Conclusion
This study reveals profound global inequalities in hematologic malignancies. Mitigating this burden requires strengthening early diagnosis and treatment in low‐SDI regions while integrating psychosocial support into global survivorship care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan Province, China.
- Department of Gastroenterology, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang City, Guangdong Province, China.
- Department of Gastrointestinal Surgery, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang City, Guangdong Province, China.
- Department of Pathology, Guangdong Medical University, Zhanjiang, China.
ORCID-Profile: Lei Ge, Yuping Yang
Förderung
- Big Data Platform of Affiliated Hospital of Guangdong Medical University, the In-Hospital Funding Clinical Research Project of the Affiliated Hospital of Guang…
- Guangdong Provincial Medical Science and Technology Research Fund Project
Zitieren
APA
Kou, Y., Chen, F., Ge, L., Tian, Y., Mao, Y., Lu, Z., Du, W., Cheng, Y., Yang, Y., & Qin, L. (2026). Global, Regional, and National Burden of Hematologic Malignancies From 1990 to 2021, With Projections of Mortality and Incidence to 2031. Psycho-Oncology. https://doi.org/10.1002/pon.70365
Vancouver
Kou Y, Chen F, Ge L, Tian Y, Mao Y, Lu Z, et al. Global, Regional, and National Burden of Hematologic Malignancies From 1990 to 2021, With Projections of Mortality and Incidence to 2031. Psycho-Oncology. 2026. doi:10.1002/pon.70365
BibTeX
@article{Kou2026,
author = {Kou, Yanqi and Chen, Fengyu and Ge, Lei and Tian, Yuan and Mao, Yitong and Lu, Zhuoyan and Du, Weimin and Cheng, Yufei and Yang, Yuping and Qin, Ling},
title = {Global, Regional, and National Burden of Hematologic Malignancies From 1990 to 2021, With Projections of Mortality and Incidence to 2031},
journal = {Psycho-Oncology},
year = {2026},
doi = {10.1002/pon.70365}
}
EUVIMED